GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro

Authors
Hong, Kyung SooAhn, June HongJang, Jong GeolLee, Jong HoKim, Hong NamKim, DonghaLee, Wonhwa
Issue Date
2020-12-17
Publisher
SPRINGERNATURE
Citation
SIGNAL TRANSDUCTION AND TARGETED THERAPY, v.5, no.1
ISSN
2095-9907
URI
https://pubs.kist.re.kr/handle/201004/117673
DOI
10.1038/s41392-020-00391-5
Appears in Collections:
KIST Article > 2020
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE